The physicians at the Retina Vitreous Center are national leaders in clinical trials and therefore are able to bring state-of-the art therapies to their patients.  Below is a selection of some of the trials available to RVC patients for a variety of retinal conditions.  If you are interested to determine if you might be eligible for a clinical trial, request an appointment. To learn more about the trials below, click the link to see its description on the federal website ClinicalTrials.gov. 

Age-related Macular Degeneration

• CATT – Lucentis versus Avastin for wet macular degeneration
• DENALI – Lucentis alone versus Lucentis plus photodynamic therapy for wet macular degeneration
• VEGF Trap-Eye 0508 - VEGF-Trap for wet macular degeneration
• VEGF Trap-Eye 0605 (VIEW 1) - VEGF-Trap for wet macular degeneration 
• VEGF Trap-Eye 0702 – VEGF-Trap for macular degeneration

Vein Occlusion 

• BRAVO – Lucentis for branch retinal vein occlusion
• CRUISE - Lucentis for central retinal vein occlusion
• SCORE – triamcinolone acetonide for branch or central retinal vein occlusion

Diabetic Retinopathy

• RISE – Lucentis for diabetic macular edema
• VEGF Trap-Eye 0706 (Da Vinci) – VEGF-Trap for diabetic macular edema

Others

• MIVI-TRUST – microplasmin for non-surgical lysis of vitreomacular adhesion